Acamprosate
Back to searchMolecule Structure
Scientific Name
Acamprosate
Description of the Drug
Acamprosate is a medication used to maintain alcohol abstinence in patients with alcohol dependence.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00659
http://www.drugbank.ca/drugs/DB00659
Brand Name(s)
Not Available
Company Owner(s)
Glenmark Generics Ltd, Barr Laboratories Inc Sub Teva Pharmaceuticals Usa, Mylan Pharmaceuticals Inc, Zydus Pharmaceuticals Usa Inc, Forest Laboratories Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
GABA-A receptor; anion channel | PROTEIN COMPLEX GROUP | POSITIVE MODULATOR | CHEMBL2093872 |
Glutamate [NMDA] receptor | PROTEIN COMPLEX GROUP | ANTAGONIST | CHEMBL2094124 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL41983 | |
PharmGKB | PA10344 | |
Human Metabolome Database | HMDB0014797 | |
DrugBank | DB00659 | |
PubChem: Thomson Pharma | 15120629 | |
PubChem | 71158 | |
LINCS | LSM-43113 | |
Nikkaji | J309.380H | |
EPA CompTox Dashboard | DTXSID3044259 | |
DrugCentral | 38 | |
ChemicalBook | CB6918820 | |
Guide to Pharmacology | 7106 | |
rxnorm | ACAMPROSATE | ACAMPROSATE CALCIUM |
ChEBI | 51041 | |
ZINC | ZINC000001554588 |